One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)

NCT00246467 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Plague

Interventions

BIOLOGICAL: Alhydrogel
BIOLOGICAL: rF1 and rV protein antigens

Sponsor

PharmAthene UK Limited

Collaborators

[object Object]